Article
New Opportunities for Targeting the Androgen Receptor in Prostate Cancer.
Cold Spring Harbor perspectives in medicine - 3 Dec 2018
Centenera Margaret M, Selth Luke A, Ebrahimie Esmaeil, Butler Lisa M, Tilley Wayne D
Abstract excerpt
Recent genomic analyses of metastatic prostate cancer have provided important insight into adaptive changes in androgen receptor (AR) signaling that underpin resistance to androgen deprivation therapies. Novel strategies are required to circumvent these AR-mediated resistance mechanisms and thereby improve prostate cancer survival. In this review, we present a summary of AR structure and function and discuss...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
